In February 2025, global markets are experiencing a mix of geopolitical tensions and economic uncertainty, with U.S. stocks facing downward pressure due to concerns about consumer spending and potential new tariffs. Amid this environment, identifying undervalued stocks becomes crucial as investors seek opportunities that may offer resilience or growth potential despite broader market challenges. Top 10 Undervalued Stocks Based On Cash Flows Name Current Price Fair Value (Est) Discount (Est) MINISO Group Holding (NYSE:MNSO) US$20.68 US$41.04 49.6% Vimi Fasteners (BIT:VIM) €0.96 €1.91 49.8% OSAKA Titanium technologiesLtd (TSE:5726) ¥1860.00 ¥3696.77 49.7% Power Wind Health Industry (TWSE:8462) NT$113.50 NT$226.14 49.8% CD Projekt (WSE:CDR) PLN220.70 PLN441.19 50% Vestas Wind Systems (CPSE:VWS) DKK102.40 DKK204.54 49.9% Thunderbird Entertainment Group (TSXV:TBRD) CA$1.69 CA$3.36 49.6% Hanwha Aerospace (KOSE:A012450) ₩680000.00 ₩1356955.59 49.9% CGN Mining (SEHK:1164) HK$1.43 HK$2.85 49.8% Shenzhen Anche Technologies (SZSE:300572) CN¥18.69 CN¥37.15 49.7% Click here to see the full list of 925 stocks from our Undervalued Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Almirall Overview: Almirall, S.A. is a biopharmaceutical company focused on the purchase, manufacture, storage, and sale of skin-health medicines across Europe, the Middle East, the United States, Asia, and Africa with a market cap of €2.08 billion. Operations: Almirall's revenue primarily stems from its activities in the biopharmaceutical sector, specifically through the production and distribution of skin-health medications across various regions including Europe, the Middle East, the United States, Asia, and Africa. Estimated Discount To Fair Value: 36.8% Almirall is trading at €9.76, significantly below its estimated fair value of €15.43, indicating potential undervaluation based on cash flows. Recent earnings show a turnaround with net income of €10.15 million compared to a loss last year, and sales growth from €894.52 million to €985.72 million in 2024. The company forecasts 10%-13% sales growth for 2025 and expects profitability within three years, despite slower revenue growth than the broader market expectations. Our expertly prepared growth report on Almirall implies its future financial outlook may be stronger than recent results. Click here to discover the nuances of Almirall with our detailed financial health report.BME:ALM Discounted Cash Flow as at Feb 2025 Norsk Hydro Overview: Norsk Hydro ASA is involved in global power production, bauxite extraction, alumina refining, aluminium smelting, and recycling activities with a market cap of NOK131.57 billion. Story Continues Operations: The company's revenue segments include Hydro Energy (NOK10.59 billion), Hydro Extrusions (NOK75.13 billion), Hydro Metal Markets (NOK81.39 billion), Hydro Aluminium Metal (NOK55.49 billion), and Hydro Bauxite & Alumina (NOK54.22 billion). Estimated Discount To Fair Value: 34% Norsk Hydro's current trading price of NOK66.62 is well below its estimated fair value of NOK101.01, highlighting potential undervaluation based on cash flows. The company's earnings are projected to grow significantly at 24.8% annually over the next three years, outpacing the Norwegian market average. Recent news includes a completed share buyback and a partnership with Rio Tinto for carbon capture technology development, reflecting strategic initiatives alongside financial performance improvements such as increased revenue and net income in Q4 2024. The analysis detailed in our Norsk Hydro growth report hints at robust future financial performance. Take a closer look at Norsk Hydro's balance sheet health here in our report.OB:NHY Discounted Cash Flow as at Feb 2025 AtkinsRéalis Group Overview: AtkinsRéalis is an integrated professional services and project management company operating globally, with a market cap of CA$12.40 billion. Operations: The company's revenue segments include Capital at CA$126.66 million, Nuclear at CA$1.30 billion, LSTK Projects at CA$264.84 million, and a Segment Adjustment of CA$7.67 billion. Estimated Discount To Fair Value: 21% AtkinsRéalis Group's current price of CA$71.07 is significantly below its estimated fair value of CA$89.92, indicating potential undervaluation based on cash flows. Earnings are forecast to grow substantially at 27% annually, surpassing the Canadian market average. Recent strategic wins include a major digital systems contract with Network Rail and a joint venture for nuclear refurbishment with Ontario Power Generation, enhancing its project backlog and demonstrating robust operational capabilities in key sectors. The growth report we've compiled suggests that AtkinsRéalis Group's future prospects could be on the up. Dive into the specifics of AtkinsRéalis Group here with our thorough financial health report.TSX:ATRL Discounted Cash Flow as at Feb 2025 Turning Ideas Into Actions Explore the 925 names from our Undervalued Stocks Based On Cash Flows screener here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:ALM OB:NHY and TSX:ATRL. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Three Stocks With Estimated Undervaluation Worth Considering In February 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...